Physical activity in incident patients with pulmonary arterial and chronic thromboembolic hypertension

被引:15
|
作者
Saxer, Stephanie [1 ,2 ]
Lichtblau, Mona [1 ]
Berlier, Charlotte [1 ]
Hasler, Elisabeth D. [1 ]
Schwarz, Esther, I [1 ]
Ulrich, Silvia [1 ]
机构
[1] Univ Hosp Zurich, Dept Pulmonol, Ramistr 100, CH-8091 Zurich, Switzerland
[2] Univ Lucerne, Dept Hlth Sci & Hlth Policy, Luzern, Switzerland
关键词
Physical activity; Pulmonary arterial hypertension; Actigraphy; Hemodynamics; Exercise; Pulmonary hypertension; EXERCISE; LEVEL;
D O I
10.1007/s00408-019-00248-x
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Introduction The cardinal symptom of pulmonary hypertension (PH) is dyspnea on exertion, leading to decreased activity in daily living. The aim of this study was to analyze daily physical activity in incident patients with arterial or chronic thromboembolic PH (PAH/CTEPH) and to investigate its correlation with pulmonary hemodynamics, symptoms, exercise capacity, and other outcomes. Methods Incident patients with PAH/CTEPH had a 1-week activity assessment by the arm-worn accelerometer SenseWear within - 3 months/+ 2 weeks of the diagnostic right heart catheterization (RHC) and baseline assessments including 6-minute walking distance (6MWD). Activity was correlated to RHC data at rest and exercise and to other outcomes. Results Thirty-nine PH-patients (24 PAH, 15 CTEPH, 23 females, 65(54;73) years, mean pulmonary artery pressure (mPAP) 38(30;46) mmHg, cardiac output (CO) 5.2(4.6;6.3) l/min, 6MWD 458(300;593) m) were included. 64% had a sedentary lifestyle ( < 5000 steps/day), 26% were moderately active (5000-9999 steps/day), and 10% were active. In a multivariate stepwise regression analysis including age, gender, 6MWD and hemodynamics at rest and during exercise (heart rate, mPAP, stroke volume), the 6MWD was the only independent predictor of steps/day (B = 16.8 (95% CI 11.6-22.0), p < 0.001). Conclusion Daily physical activity as steps/day assessed in incident patients with PAH/CTEPH did not well correlate with invasive hemodynamics at rest or during exercise, but very well with the 6MWD. Whether daily activity assessments provide additional information to simple walk distance on risk factor profiles during follow-up in patients with PAH/CTEPH remains to be clarified.
引用
收藏
页码:617 / 625
页数:9
相关论文
共 50 条
  • [1] Physical activity in incident patients with pulmonary arterial and chronic thromboembolic hypertension
    Stéphanie Saxer
    Mona Lichtblau
    Charlotte Berlier
    Elisabeth D. Hasler
    Esther I. Schwarz
    Silvia Ulrich
    [J]. Lung, 2019, 197 : 617 - 625
  • [2] Predictors of physical activity in pulmonary arterial and chronic thromboembolic pulmonary hypertension
    Saxer, Stephanie
    Lichtblau, Mona
    Berlier, Charlotte
    Hasler, Elisabeth
    Schwarz, Esther
    Ulrich, Silvia
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [3] Neopterin as a Biomarker in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
    Smukowska-Gorynia, Anna
    Marcinkowska, Justyna
    Chmara, Ewa
    Malaczynska-Rajpold, Katarzyna
    Slawek-Szmyt, Sylwia
    Cieslewicz, Artur
    Janus, Magdalena
    Araszkiewicz, Aleksander
    Jankiewicz, Stanislaw
    Komosa, Anna
    Olasinska-Wisniewska, Anna
    Tomaszewska, Iga
    Mularek-Kubzdela, Tatiana
    [J]. RESPIRATION, 2018, 96 (03) : 222 - 230
  • [4] Increased Antielastase Activity in Idiopathic Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
    Guo, Jingxu
    Lodge, Katharine
    Newnham, Michael
    Bunclark, Katherine
    Toshner, Mark
    Morrell, Nicholas W.
    Li, Wei
    [J]. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2018, 59 (05) : 652 - 655
  • [5] Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology
    Humbert, M.
    [J]. EUROPEAN RESPIRATORY REVIEW, 2010, 19 (115): : 59 - 63
  • [6] Riociguat for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
    Bishop, Bryan M.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2014, 71 (21) : 1839 - 1844
  • [7] Support Experienced by Patients Living with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
    Ivarsson, Bodil
    Ekmehag, Bjorn
    Sjoberg, Trygve
    [J]. HEART LUNG AND CIRCULATION, 2016, 25 (01): : 35 - 40
  • [8] Information Experiences and Needs in Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension
    Ivarsson, Bodil
    Ekmehag, Bjorn
    Sjoberg, Trygve
    [J]. NURSING RESEARCH AND PRACTICE, 2014, 2014
  • [9] Clinical efficacy of Macitentan in patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
    Nashat, Heba
    Da Costa, Rosa
    Barbosa, Joanna
    Harries, Carl
    Kempny, Aleksander
    Price, Laura C.
    Mc Cabe, Colm
    Gatzoulis, Michael A.
    Dimopoulos, Konstantinos
    Wort, Stephen J.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [10] Anxiety and depression disorders in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
    Harzheim, Dominik
    Klose, Hans
    Pinado, Fabiola Pena
    Ehlken, Nicola
    Nagel, Christian
    Fischer, Christine
    Ghofrani, Ardeschir
    Rosenkranz, Stephan
    Seyfarth, Hans-Juergen
    Halank, Michael
    Mayer, Eckhard
    Gruenig, Ekkehard
    Guth, Stefan
    [J]. RESPIRATORY RESEARCH, 2013, 14